MCHP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Microchip Technology Inc (MCHP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral to bearish, and insider selling activity is significantly high. While the company has shown revenue growth, its net income and EPS have dropped substantially. Analysts' ratings are mixed, with no strong consensus on upside potential. Given the lack of strong positive catalysts and the current market sentiment, it is better to hold off on investing in this stock for now.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 31.651, and moving averages are converging, showing no clear trend. The stock is trading near its S1 support level of 74.393, with further downside risk to S2 at 72.099. Overall, technical indicators suggest a neutral to bearish outlook.
The company reported Q3 revenue growth of 15.59% YoY and improved gross margins by 18.14%. Analysts like Needham, Mizuho, and Evercore have raised their price targets, reflecting optimism about the company's long-term prospects.
Insider selling has increased by 4258.22% over the last month, which could indicate a lack of confidence from insiders. Net income and EPS have dropped significantly (-165.11% and -160.00% YoY, respectively). Al Gore's investment firm divested from semiconductor companies, including Microchip, which could reflect broader concerns in the sector. Technical indicators are bearish, and the stock has a 70% chance of declining in the next week.
In Q3 2026, revenue increased by 15.59% YoY to $1.186 billion, and gross margin improved to 50.53%. However, net income dropped by -165.11% YoY to $34.9 million, and EPS fell by -160.00% YoY to $0.06. This indicates that while the company is growing revenue, profitability has significantly deteriorated.
Analyst ratings are mixed. Barclays initiated coverage with an Equal Weight rating and a $80 price target, citing risks in microcontroller market share. Needham, Mizuho, and Evercore raised their price targets to $84, $90, and $93, respectively, reflecting optimism. However, Truist and TD Cowen remain cautious with Hold ratings and lower price targets, citing limited upside and gradual demand recovery.
